Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2021
Filter by date:
Showing 973 press releases before 2021
-
AstraZeneca to divest US Synagis rights to Sobi
-
US FDA accepts regulatory submission for Lynparza maintenance therapy in newly-diagnosed, BRCA-mutated advanced ovarian cancer and grants Priority Review
-
Farxiga significantly reduced hospitalisation for heart failure or CV death in a broad patient population with type-2 diabetes in the landmark DECLARE-TIMI 58 trial
-
Year-To-Date and Q3 2018 Results
-
Divestment of rights to Alvesco, Omnaris and Zetonna to Covis Pharma
-
The landmark DECLARE-TIMI 58 cardiovascular outcomes trial of Farxiga in patients with type-2 diabetes to be featured at AHA 2018
-
Agreement with Grünenthal for rights to Nexium in Europe and Vimovo worldwide (ex-US)
-
Phase III HARMONIZE Global trial of Lokelma confirms efficacy in maintaining normal potassium levels in Asian patients with hyperkalaemia
-
AstraZeneca strengthens and expands oncology development and commercialisation collaboration with Innate Pharma
-
AstraZeneca to present new data demonstrating breadth of research portfolio in renal disease at ASN Kidney Week 2018
Latest articles and press releases
All of our latest press releases and articles are available to explore
